← Evidence map

ArticleNature2026

A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases.

Yi Zang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42271063